Scholarlink

<p>Antibiotic resistance is an increasing threat to global public health. Developing new antibiotics and alternative treatments is crucial for combating resistant strains and reducing the global health burden. Hence, we synthesized and evaluated the antitubercular potential of dihydropyridine derivatives. A simplified Biginelli condensation method was employed to synthesize novel 3,4-dihydropyrimidine derivatives (4a–4m) via a one-pot three-component reaction using various substituted benzaldehydes. Reaction completion was monitored via thin-layer chromatography. The structures of the compounds were confirmed by FT-IR, mass spectrometry, <sup>1</sup>H NMR, and <sup>13</sup>C NMR spectroscopy, and melting points were determined by differential scanning calorimetry. ADMET screening was performed for all synthesized compounds. Selected compounds were tested for their antibacterial and anti-tubercular activity against gram-positive and gram-negative bacteria. ADMET screening identified eight potential compounds: 4c, 4e, 4f, 4g, 4i, 4j, 4k, and 4m. The literature emphasized DprE1 as a critical target for anti-tubercular activity. Molecular docking studies revealed promising binding affinities for compounds 4g (−&#xa0;7.67), 4d (−&#xa0;7.316), 4e (−&#xa0;7.062), and 4c (−&#xa0;7.042) against DprE1. Furthermore, to study the binding stability and interaction patterns of protein–ligand complexes, a molecular dynamics simulation was performed. The stability of the protein–ligand complex was confirmed by low protein RMSD values and minimal fluctuations in ligand RMSD, indicating a stable binding pose throughout the 200&#xa0;ns simulation. These compounds also exhibited significant antibacterial activity against gram-positive and gram-negative bacteria compared to standard drugs. In-vitro antitubercular assays against the H37Rv strain demonstrated moderate to notable efficacy relative to the standard reference drug. The findings suggest that these compounds could serve as promising drug candidates. Further development may lead to their use as effective antituberculosis agents in future research.</p> Graphical abstract <p>Various studies of 3,4-dihydropyrimidine derivatives synthesized via Biginalli reaction</p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Synthesis, molecular docking, molecular dynamic simulation and biological evaluation of novel 3,4-dihydropyridine derivatives as potent antituberculosis agents

  • 期刊论文

  • 发表日期：

    2025年7月1日

查看全文
  • Riya Khandelwal,
  • Mahesh Vasava,
  • Vijay Kevlani,
  • Chintan Parmar,
  • Apurva Prajapati,
  • Hitesh Patel,
  • Paresh Patel

摘要

Antibiotic resistance is an increasing threat to global public health. Developing new antibiotics and alternative treatments is crucial for combating resistant strains and reducing the global health burden. Hence, we synthesized and evaluated the antitubercular potential of dihydropyridine derivatives. A simplified Biginelli condensation method was employed to synthesize novel 3,4-dihydropyrimidine derivatives (4a–4m) via a one-pot three-component reaction using various substituted benzaldehydes. Reaction completion was monitored via thin-layer chromatography. The structures of the compounds were confirmed by FT-IR, mass spectrometry, 1H NMR, and 13C NMR spectroscopy, and melting points were determined by differential scanning calorimetry. ADMET screening was performed for all synthesized compounds. Selected compounds were tested for their antibacterial and anti-tubercular activity against gram-positive and gram-negative bacteria. ADMET screening identified eight potential compounds: 4c, 4e, 4f, 4g, 4i, 4j, 4k, and 4m. The literature emphasized DprE1 as a critical target for anti-tubercular activity. Molecular docking studies revealed promising binding affinities for compounds 4g (− 7.67), 4d (− 7.316), 4e (− 7.062), and 4c (− 7.042) against DprE1. Furthermore, to study the binding stability and interaction patterns of protein–ligand complexes, a molecular dynamics simulation was performed. The stability of the protein–ligand complex was confirmed by low protein RMSD values and minimal fluctuations in ligand RMSD, indicating a stable binding pose throughout the 200 ns simulation. These compounds also exhibited significant antibacterial activity against gram-positive and gram-negative bacteria compared to standard drugs. In-vitro antitubercular assays against the H37Rv strain demonstrated moderate to notable efficacy relative to the standard reference drug. The findings suggest that these compounds could serve as promising drug candidates. Further development may lead to their use as effective antituberculosis agents in future research.

Graphical abstract

Various studies of 3,4-dihydropyrimidine derivatives synthesized via Biginalli reaction